Nurse Confesses to Drugging, Dismembering Son in Udine Court Hearing

During a custody confirmation hearing before the preliminary investigations judge (GIP) at the Udine Tribunal, 61-year-old nurse Lorena Venier confessed to murdering and dismembering her 35-year-old son, Alessandro. Venier detailed the killing, stating: “We decided to kill him by putting him to sleep: I emptied an entire blister of medication into lemonade, but it wasn’t enough. At that point, I gave him two insulin injections since he wouldn’t fall asleep completely. I had the insulin at home for about 5 years. I took it from my workplace because at the time I had decided to use it to kill myself.”

Venier further explained the prolonged death to investigators: “We stunned him with a sleeping pill around 5:30 PM, but he only died around 11:00 PM because we couldn’t finish him off.” She described subsequent attempts: “Once the insulin took effect, we tried to suffocate him with a pillow, but Alessandro kept reacting, even though he was weak.”

Regarding the dismemberment, Venier told the court: “The plan didn’t involve cutting him up. I did that alone when we realized the body wouldn’t fit in the bin where it was supposed to decompose, while we waited to scatter the remains in the mountains. At that point, I cut him into three pieces with a hacksaw, and Mailyn transported him to the garage and covered him with lime.”

Riproduzione riservata © Copyright ANSA

share this news:

Facebook
Twitter
WhatsApp
Telegram

看看这些相关内容

瑞典完成首例免抗排异胰岛移植

瑞典乌普萨拉大学研究团队日前在《新英格兰医学杂志》发表突破性成果:全球首例1型糖尿病患者在接受基因编辑胰岛细胞移植后,未使用免疫抑制剂且未出现排异反应。 该实验性疗法代号UP421,通过CRISPR基因编辑技术改造捐赠者胰岛细胞,使其能规避患者免疫系统攻击。移植细胞被植入患者前臂,术后12周仍保持活性并分泌胰岛素。研究团队强调,本次移植细胞数量极少,产生的胰岛素含量微小,属于原理验证阶段而非成熟疗法。 意大利糖尿病专家指出,这是人类首次证实基因编辑胰腺细胞可在无免疫抑制条件下存活。若该技术通过后续验证,将大幅扩展胰岛移植适用人群,消除免疫抑制治疗风险,使患者摆脱每日胰岛素注射,显著提升治疗安全性和生活质量。

Read More